Crescent Capital BDC (CCAP) Cash & Equivalents (2021 - 2026)

Crescent Capital BDC (CCAP) has 6 years of Cash & Equivalents data on file, last reported at $1.8 million in Q1 2026.

• Quarterly Cash & Equivalents fell 90.24% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 90.24% YoY) and the FY2025 annual result came in at $5.0 million, down 87.21% from the prior year.
• Cash & Equivalents declined to $1.8 million in Q1 2026, from $5.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $39.4 million in Q4 2024 to a low of $1.1 million in Q2 2025.
• A 5-year average of $11.0 million and a median of $8.2 million in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2025 — Cash & Equivalents soared 1477.15% — and 2026, when it tumbled 90.24%.
• Tracing CCAP's Cash & Equivalents over 5 years: stood at $8.2 million in 2022, then soared by 104.68% to $16.7 million in 2023, then surged by 136.2% to $39.4 million in 2024, then plunged by 87.21% to $5.0 million in 2025, then tumbled by 64.19% to $1.8 million in 2026.
• The last three Cash & Equivalents figures came in at $1.8 million (Q1 2026), $5.0 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.